BioSpace News Archive

The CNS Summit, a community passionate about shaping the future of the life sciences with a focus on collaboration, innovation and technology, today announced the agenda for their 10th anniversary Summit

Three years is the longest accreditation time period NCQA designates for organizations.

Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) (“Cryoport”), the world’s leading temperature-controlled logistics solutions company dedicated to the life sciences industry, today announced its Board of Directors has unanimously authorized a share repurchase program, under which Cryoport may repurchase up to $15 million of its outstanding common stock.

In Its Sixth Year, the Global Campaign Highlights Ways to Reduce the Impact of a Condition that Contributes to One in Four Deaths Worldwide

First liquid biopsy test reimbursed in Switzerland for colon cancer screening through private outpatient supplementary insurance product offered by Helsana

Twenty new abstracts underscore AbbVie’s commitment to advancing standards of care for people living with serious skin diseases

Absorption Systems, a global leader in translational medicine, pharmacokinetic testing of drugs, and cell and gene therapy, announces that it has been awarded a 5 year IDIQ (Indefinite Delivery Indefinite Quantity) contract, for a total amount of $3.5 million, by the U.S. Food and Drug Administration (FDA).

Physician practices struggling to comply with state government restrictions on opioid prescriptions now have an easy means of satisfying the requirements designed to prevent overdoses and drug misuse.

Galderma, a global leader in skin health focused on developing innovative aesthetic solutions, recently announced the Phase 2 clinical trial results for its novel ready-to-use investigational botulinum toxin, QM1114

W2O, the leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, today announced the acquisition of Arcus Medica.